Heatstroke Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Clinical Trials
• Forums

Efficacy and Safety of Ryanodex® (EGL-4104) as Adjuvant Treatment in Subjects With Exertional Heat Stroke (EHS)
Condition:   Heat StrokeIntervention:   Drug: Dantrolene sodium for injectable suspensionSponsors:   Eagle Pharmaceuticals, Inc.;   QuintilesNot yet recruiting - verified July 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2015 Category: Research Source Type: clinical trials

Efficacy and Safety of Ryanodex® (EGL-4104) as Adjuvant Treatment in Subjects With Exertional Heat Stroke (EHS)
Condition:   Heat StrokeIntervention:   Drug: Dantrolene sodium for injectable suspensionSponsors:   Eagle Pharmaceuticals, Inc.;   QuintilesNot yet recruiting - verified August 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2015 Category: Research Source Type: clinical trials

Efficacy and Safety of Ryanodex® (EGL-4104) as Adjuvant Treatment in Subjects With Exertional Heat Stroke (EHS)
Condition:   Heat StrokeIntervention:   Drug: Dantrolene sodium for injectable suspensionSponsors:   Eagle Pharmaceuticals, Inc.;   QuintilesNot yet recruiting - verified July 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2015 Category: Research Source Type: clinical trials